Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cho

Showing results (901-910 of 1,047) with videos related to

Pageof 105
Sort By:
Oxidative Medicine and Cellular Longevity|June 9, 2022
Diosgenin: An Updated Pharmacological Review and Therapeutic PerspectivesPrabhakar Semwal, Sakshi Painuli, Tareq Abu-Izneid, et al.
Chinese Medicine|September 29, 2022
Eryngium caeruleum: an update on ethnobotany, phytochemistry and biomedical applicationsDmitryi Alexeevich Konovalov, Edgardo Avendaño Cáceres, Ekaterina Aleksandrovna Shcherbakova, et al.
Iranian Journal of Pharmaceutical Research : IJPR|November 23, 2020
Multivesicular Liposome (Depofoam) in Human DiseasesBahare Salehi, Abhay P Mishra, Manisha Nigam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapyS Park, M-H Lee, M Seong, et al.
Medcomm|September 2, 2025
Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and BeyondRajni Bala, Reecha Madaan, Onkar Bedi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancerJon-Paul J Voroney, Andrew Hope, Max R Dahele, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 26, 2025
Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to DiseaseDengxiong Li, Zhipeng Wang, Qingxin Yu, et al.
The Lancet. Oncology|February 15, 2018
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trialMichael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Nutrients|July 3, 2019
Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic AgentsBahare Salehi, Patrick Valere Tsouh Fokou, Lauve Rachel Tchokouaha Yamthe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2025
Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort studySikai Wu, Minhua Ye, Guochao Zhang, et al.
Pageof 105

Showing results (901-910 of 1,047) with videos related to

Sort By:
Pageof 105
Oxidative Medicine and Cellular Longevity|June 9, 2022
Diosgenin: An Updated Pharmacological Review and Therapeutic PerspectivesPrabhakar Semwal, Sakshi Painuli, Tareq Abu-Izneid, et al.
Chinese Medicine|September 29, 2022
Eryngium caeruleum: an update on ethnobotany, phytochemistry and biomedical applicationsDmitryi Alexeevich Konovalov, Edgardo Avendaño Cáceres, Ekaterina Aleksandrovna Shcherbakova, et al.
Iranian Journal of Pharmaceutical Research : IJPR|November 23, 2020
Multivesicular Liposome (Depofoam) in Human DiseasesBahare Salehi, Abhay P Mishra, Manisha Nigam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapyS Park, M-H Lee, M Seong, et al.
Medcomm|September 2, 2025
Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and BeyondRajni Bala, Reecha Madaan, Onkar Bedi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancerJon-Paul J Voroney, Andrew Hope, Max R Dahele, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 26, 2025
Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to DiseaseDengxiong Li, Zhipeng Wang, Qingxin Yu, et al.
The Lancet. Oncology|February 15, 2018
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trialMichael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Nutrients|July 3, 2019
Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic AgentsBahare Salehi, Patrick Valere Tsouh Fokou, Lauve Rachel Tchokouaha Yamthe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2025
Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort studySikai Wu, Minhua Ye, Guochao Zhang, et al.
Pageof 105